Olaparib Drugs market size is estimated to be worth US$ 2114 million in 2022 and is forecast to a readjusted size of US$ 3078 million by 2028 with a CAGR of 5% during the forecast period 2022-2028. Olafarib is used to treat breast cancer,ovarian cancer,fallopian tube cancer,pancreatic cancer,prostate cancer,peritoneal cancer(a membrane that envelops the interior […]
Category Archives: Health
Axicabtagene Ciloleucel market size is expected to grow from US$ 1244 million in 2021 to US$ 6854 million by 2028, at a CAGR of 24% during the forecast period 2022-2028. It used for the treatment of adult patients with recurrent or refractory large non-cell lymphoma after two or more systemic treatments,including diffuse large non-cell lymphoma(non-cell […]
The US sleep-wake disorder market is estimated to grow at a CAGR of 6.0% during the forecast period. The growth of the sleep-wake disorder market in the US is attributed to the presenvce of well-established healthcare infrastructure, rise in awareness among people, and an increase in the prevalence of sleep disorders. As per the World […]
The UK sleep-wake disorder market is estimated to grow at a CAGR of 6.2% during the forecast period. UK contributes a considerable share in the market due to the presence of a significant number of people with behavioral health disorders and the growing awareness of sleep disorders in the country. Mental Health First Aid (MHFA) […]
The North American sleep-wake disorder market is estimated to grow at a CAGR of 5.9% during the forecast period. The growth of the sleep-wake disorder market in North America is attributed to the well-established healthcare infrastructure, rise in awareness among people, and an increase in the prevalence of sleep disorders. As per the World Bank, […]
France respiratory drug market was valued more than $1.3 billion in 2018 and is anticipated to grow at a substantial rate of 6.0% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in the country. […]
The European sleep-wake disorder market is estimated to grow at a CAGR of 5.5% during the forecast period. The key driving factor of the market in the region is the increasing sleep-wake disorders due to various behavioral health issues of the population which is expected to promote the demand for sleep-wake disorder treatment solutions, thereby […]
The China sleep-wake disorder market is estimated to grow at a CAGR of 6.5% during the forecast period. China is estimated to have a considerable share in the Asia-Pacific sleep-wake disorder market. Sleep insufficiency, drowsiness, and insomnia are prevalent in Chinese adolescents. Owing to the rapid industrialization and urbanization in the country; the younger adults […]
The Asia-Pacific sleep-wake disorder market is estimated to grow at a CAGR of 6.3% during the forecast period. Countries in Asia-Pacific that are contributing to the market growth include China, India, and Japan. China is the largest contributor to the Asia-Pacific sleep-wake disorder market. The market in the region is largely driven by increasing workplace […]
Health
Global Neuroendocrine Carcinoma Drug Market Size, Share and Trends Analysis Report, By Indication (Gastric Neuroendocrine Tumors, Lung Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, and Appendicular Neuroendocrine Tumors), By Treatment Type (Somatostatin Analogy, Targeted Therapy, and Chemotherapy), By End-User (Hospital, Clinics, and Others), Forecast (2022-2028)
The global neuroendocrine carcinoma drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Neuroendocrine carcinomas usually form solid tumors and they are the most common type of cancer as neuroendocrine carcinomas carcinoma include prostate cancer, breast cancer, lung cancer, and colorectal cancer.The market is driven by growing awareness of […]